HB0049 would substantially revise Maryland abortion law by replacing the existing viability-based framework with a “heartbeat” standard. The bill defines terms such as fetal heartbeat, gestational age, gestational sac, physician, pregnancy, and standard medical practice, and then prohibits a physician from knowingly performing, inducing, or attempting an abortion once a detectable fetal heartbeat is found, subject to limited exceptions. It also requires physicians to use medically appropriate testing to determine whether cardiac activity is present, to document gestational age and testing results, and to prepare written records when an abortion is performed for a medical emergency or other health-related reason.
The bill also imposes extensive informed-consent and ultrasound/sonogram requirements before an abortion may be performed, including disclosures about risks, alternatives, fetal development, and the availability of public benefits and support services. It creates a private civil enforcement scheme under which any non-state actor may sue alleged violators or those who aid and abet a prohibited abortion, with statutory damages of at least $10,000 per abortion, injunctive relief, and attorney’s fees. The bill further bars state enforcement of the heartbeat restrictions, limits standing and defenses in these suits, and adds immunity and fee-shifting provisions designed to protect the law from constitutional challenges and to deter pre-enforcement litigation.
In terms of state law, HB0049 would repeal and replace several existing abortion-related provisions in the Health-General Article, including the current statutory sections addressing abortion procedures, information, and refusal to participate or refer. It would also remove the current viability-based language and the existing protections against state interference in abortion decisions, while preserving and expanding other abortion-regulating provisions. The bill is structured to take effect on October 1, 2026, and includes severability language to preserve remaining provisions if any part is struck down.
The general sentiment reflected in the bill text is strongly anti-abortion and regulatory, with the legislation framed as protecting fetal life and maternal health from the outset of pregnancy. Because there are no committee transcripts or recorded votes provided, there is no documented floor or committee debate in the supplied materials; however, the bill’s structure suggests an intent to create a highly enforceable abortion restriction with private litigation as the primary enforcement mechanism. The title “Heartbeat Bill” and the detailed findings about fetal cardiac activity indicate a policy approach aligned with fetal-heartbeat abortion bans used in other states.
The main points of contention likely center on the heartbeat threshold itself, the private-enforcement model, and the bill’s extensive informed-consent and ultrasound mandates. Opponents would likely object to the ban before viability, the use of civil suits by private individuals, the damages and fee provisions, and the restrictions on defenses and state intervention; supporters would likely emphasize fetal cardiac activity, informed consent, and the state’s asserted interest in protecting unborn life. The bill also appears to anticipate constitutional challenges by limiting standing, asserting immunity, and attempting to insulate enforcement from judicial review.
HB0049 would overhaul Maryland’s abortion statutes by replacing the current viability-based standard with a prohibition on abortions after detection of fetal cardiac activity, except in limited emergency circumstances and other specified exceptions. It would amend the Health-General Article to require physician-only performance of abortions, impose new documentation and informed-consent obligations, and authorize private civil enforcement against providers and those who aid or abet prohibited abortions. Existing statutory protections against state interference and related abortion-procedure provisions would be repealed or rewritten, significantly changing the legal duties of physicians, clinics, and potential litigants.
The bill’s text reflects a strongly pro-restriction, anti-abortion policy stance, emphasizing fetal heartbeat, maternal health, and state interest in protecting life. No committee testimony or vote record was provided, so there is no direct evidence of bipartisan support or opposition in the supplied materials. Based on the bill’s design and title, the measure appears intended to appeal to abortion opponents and to provoke substantial opposition from abortion-rights advocates, medical providers, and civil-liberties groups.
The most likely points of contention are the shift from viability to fetal heartbeat as the legal cutoff, the private-right-of-action enforcement scheme, and the extensive informed-consent and ultrasound requirements. Critics would likely focus on the bill’s potential to restrict access to abortion earlier in pregnancy, its civil-damages structure, and its limitations on defenses, standing, and state intervention; supporters would likely argue that it protects unborn life and ensures informed decision-making. The bill also raises likely disputes over medical judgment, emergency exceptions, and whether the private-enforcement model is intended to evade or withstand constitutional review.